2022 Annual Meeting | S2 - Behavioral Neurology
Program Materials Program Evaluations
| Ronald C. Petersen, MD, PhD, FAAN | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| J. E. Ahlskog, MD, PhD | Dr. Ahlskog has received publishing royalties from a publication relating to health care. |
| Bradley F. Boeve, MD, FAAN | Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care. |
| Neill R. Graff-Radford, MD, FAAN | The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care. |
| Richard J. Caselli, MD, FAAN | The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona. |
| David S. Knopman, MD, FAAN | Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
| Dennis W. Dickson, MD | Dr. Dickson has nothing to disclose. |
| Clifford R. Jack, Jr., MD | The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic. |
| Keith A. Josephs, Jr., MD, FAAN | Dr. Josephs has nothing to disclose. |
| Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN | Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB. |
| Mira Didic, MD | No disclosure on file |
| Nilufer Taner, MD, PhD, FAAN | The institution of Dr. Taner has received research support from NIH. |
| Yonas E. Geda, MD | The institution of Dr. Geda has received research support from NIH. Dr. Geda has received intellectual property interests from a discovery or technology relating to health care. |
| Mary M. Machulda, PhD | The institution of Dr. Machulda has received research support from NIH. |
| Val J. Lowe, MD | Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals. |
| Jennifer Whitwell, PhD | The institution of Dr. Whitwell has received research support from NIH. |
| Bryan K. Woodruff, MD | The institution of Dr. Woodruff has received research support from National Institute on Aging. |
| Florence Pasquier, MD | Dr. Pasquier has nothing to disclose. |
| No disclosure on file | |
| Rodolfo Savica, MD, PhD, FAAN | The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc. |
| Prashanthi Vemuri, PhD | The institution of Dr. Vemuri has received research support from NIH. |
| Niall Pender, PhD | No disclosure on file |
| Kimiko Domoto-Reilly, MD | Dr. Domoto-Reilly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedBridge. The institution of Dr. Domoto-Reilly has received research support from Lawson Health Research Institute. The institution of Dr. Domoto-Reilly has received research support from NIH. The institution of Dr. Domoto-Reilly has received research support from Biogen. The institution of Dr. Domoto-Reilly has received research support from Lewy Body Dementia Association. The institution of Dr. Domoto-Reilly has received research support from Garvey Institute for Brain Health Solutions. The institution of Dr. Domoto-Reilly has received research support from Cognition Therapeutics. The institution of Dr. Domoto-Reilly has received research support from Takayama Family. |
| Jeremiah Aakre, MPH | Mr. Aakre has nothing to disclose. |
| Gregory S. Day, MD, MSc, FAAN | Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a 好色先生al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities. |
| Jonathan Graff-Radford, MD, FAAN | Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD . |
| David T. Jones, MD | Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care. |
| Jeremie Pariente | No disclosure on file |
| Julio C. Rojas-Martinez, MD, PhD | Dr. Rojas-Martinez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferrer International, S.A.. The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. The institution of Dr. Rojas-Martinez has received research support from Amylyx. |
| Joseph Duffy | The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care. |
| Christine MacDonald, PhD | The institution of Dr. MacDonald has received research support from NIH. The institution of Dr. MacDonald has received research support from Department of Defense. |
| Katherine Turk, MD | The institution of Dr. Turk has received research support from Alzheimer's Association. The institution of Dr. Turk has received research support from US Department of Veterans Affairs. |
| Michelle M. Mielke, PhD | Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. |
| Farwa Ali, MD | Dr. Ali has nothing to disclose. |
| Hugo Botha, MD | Dr. Botha has received research support from NIH. An immediate family member of Dr. Botha has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. |
| Maria Vassilaki, MD, PhD | Dr. Vassilaki has stock in Abbott Laboratories. Dr. Vassilaki has stock in Johnson and Johnson. Dr. Vassilaki has stock in Medtronic. Dr. Vassilaki has stock in Amgen. Dr. Vassilaki has stock in AbbVie. Dr. Vassilaki has stock in Merck. The institution of Dr. Vassilaki has received research support from NIH. The institution of Dr. Vassilaki has received research support from European Union/ St. Anne's University Hospital Brno, Czech Republic. The institution of an immediate family member of Dr. Vassilaki has received research support from Avobis Bio, LLC. |
| Bharti Manwani, MD | Dr. Manwani has nothing to disclose. |
| Heather Clark | The institution of Heather Clark has received research support from NIH. Heather Clark has received publishing royalties from a publication relating to health care. |
| Walter Kremers | The institution of Walter Kremers has received research support from NIH. The institution of an immediate family member of Walter Kremers has received research support from NIH. |
| Rezaul Khandker | Rezaul Khandker has received personal compensation for serving as an employee of Merck & Co., Inc.. Rezaul Khandker has stock in Merck & Co., Inc.. |
| Vijay K. Ramanan, MD, PhD, FAAN | Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daridorexant trial for AD prevention (funded by Weston Family Foundation). The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. The institution of Dr. Ramanan has received research support from Expert Perspectives in Medicine. The institution of Dr. Ramanan has received research support from ADLM (webinar supported by educational grant from Roche). The institution of Dr. Ramanan has received research support from American College of Radiology. Dr. Ramanan has received research support from Clinical Care Options. Dr. Ramanan has received research support from PeerView Institute (webinar supported by educational grant from Lilly). Dr. Ramanan has received personal compensation in the range of $5,000-$9,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI. |
| Leila Sellami, MD | Dr. Sellami has nothing to disclose. |
| Anna Castillo | Anna Castillo has nothing to disclose. |
| Juneyoung Lee, PhD | Juneyoung Lee, PhD has nothing to disclose. |
| Marie Ryan, MRCPI | Dr. Ryan has nothing to disclose. |
| Rene Utianski | Rene Utianski has nothing to disclose. |
| Dario Saracino | Dario Saracino has nothing to disclose. |
| Wentao Li, MD | Dr. Li has nothing to disclose. |
| Farid Chekani, PhD | Mr. Chekani has received personal compensation for serving as an employee of Merck & Co., Inc.. |
| Carson Finger | Carson Finger has nothing to disclose. |
| Rabe' Alhurani, MBBS | Dr. Alhurani has nothing to disclose. |
| Christine Cliatt Brown, MD | The institution of Dr. Cliatt Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. |
| Calvin W. Howard, MD | Dr. Howard has or had stock in CogNet.Dr. Howard has received intellectual property interests from a discovery or technology relating to health care. |
| Alicia Algeciras-Schimnich | Alicia Algeciras-Schimnich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Alicia Algeciras-Schimnich has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fujirebio Diagnostics. Alicia Algeciras-Schimnich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. |
| Carolyn Parsey, PhD | Dr. Parsey has received research support from NIH/NINDS. Dr. Parsey has received research support from Ellison Foundation. |
| Rodolfo G. Gatto, MD, PhD | Dr. Gatto has nothing to disclose. |
| Isabelle Le Ber, MD, PhD | Dr. Le Ber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Therapeutics. Dr. Le Ber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. |